logo
Select company
Select metric
-1661.18%EBITDA Margin
VS
Market
4
Sector
16
Industry
30
History
100
$ 1.11Close
$ 0.77 - $ 1.54 52-Week Range
Ticker Information

Ticker

RNXT

Company Name

RENOVORX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RENOVORX INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNXT - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -11M-1661.18%$ 662K
3/31/2025$ -10.51M-4380%$ 240K
12/31/2024$ -9.19M-21374.42%$ 43K
9/30/2024$ -9.05M0%$ 0
6/30/2024$ -8.01M0%$ 0
3/31/2024$ -7.94M0%$ 0
12/31/2023$ -10.12M0%$ 0
9/30/2023$ -9.18M0%$ 0
6/30/2023$ -9.91M0%$ 0
3/31/2023$ -10.2M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RENOVORX INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, RENOVORX INC's average EBITDA % has been -9138.53%.
  • The median EBITDA % for RENOVORX INC during this period was -4380%
  • RENOVORX INC reached its highest EBITDA % over the past 5 years at -1661.18%.
  • The lowest EBITDA % recorded by RENOVORX INC in the same timeframe -21374.42%

RENOVORX INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
ADVM : ADVERUM BIOTECHNOLOGIES INC -16040.8%RLYB : RALLYBIO CORP -5458.08%ICU : SEASTAR MEDICAL HOLDING CORP -1909.79%LEXX : LEXARIA BIOSCIENCE CORP -1829.86%CLNN : CLENE INC -8655.24%COEP : COEPTIS THERAPEUTICS HOLDINGS INC -3396.38%BRTX : BIORESTORATIVE THERAPIES INC -1725.43%VTGN : VISTAGEN THERAPEUTICS INC -8532.51%LYRA : LYRA THERAPEUTICS INC -4983.38%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1330.98%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for RENOVORX INC is calculated as follows: EBITDA [ $ -3.21M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

RNXT - EBITDA Margin, Last 5 years

-21374.42%

Minimum

Dec 31, 2024

-1661.18%

Maximum

Jun 30, 2025

-9138.53%

Average

-4380%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%